# Trade Mark Journal No.2026/011 13 March 2026

## WO0000001904001 (5)

Office of origin: Republic of Korea

Date of International Registration:19 January 2026
Date of designation in the UK: 19 January 2026

International priority date claimed: 29 July 2025 (Republic of Korea) (4020250137830)

Class 5
  Pharmaceutical preparations for human use; antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of inflammatory diseases.

CELLTRION, INC.

Representative: JIDAM IP LAW FIRM, A-201, U Space 2, 670, Deawangpangyo-ro,, Bundang-gu, Seongnam-si, Gyeonggi-do, REPUBLIC OF KOREA